News

The collaboration will focus on three microRNA targets, which include Regulus’ lead cardiovascular/metabolic disease program targeting microRNA-33 for the treatment of atherosclerosis. According to the agreement, AstraZeneca will

The company has developed For Your Health – Calcium & Vitamin D as part of Nouveau Life’s focus on health concerns for aging adults and is at present

The company invested $80m in the new facility which encompasses a current Good Manufacturing Practice (cGMP) grade pilot plant and office space. The 60,000ft² facility will begin production

The multicentre, open-label study is designed to assess safety and tolerability of SOR-C13, in addition to pharmacokinetics, biomarkers and initial evidence for efficacy. Soricimed Biopharma chairman and chief

TSO is a microscopic egg of the porcine whipworm that is administered orally to regulate T-Cells and inflammatory cytokines. Coronado president and CEO Bobby W. Sandage, Jr said

According to Intellioject, Auvi-Q is the only compact auto-injector with audio and visual cues, which will guide patients and caregivers step-by-step through the injection process. Intelliject chief science

CS-TATI-1 is in preclinical development intended to target HIV TAT, which is an important target to develop new HIV drugs and also address the presentation of KSHV transactivation

The three-year, $2.5m award is a continuation to phase I SBIR grant to scan the Plasmodium falciparum proteome for protective antigens. As part of the research, ADi proteome

Atorvastatin, a generic version of Pfizer’s Lipitor, is used to lower blood cholesterol levels. In addition, Ranbaxy has received the US Food and Drug Administration approval to market